The Scientist’s LabTalk is a special edition podcast produced by The Scientist’s Creative Services Team where we explore topics at the leading edge of innovative research.

In this episode, Niki Spahich from The Scientist’s Creative Services team spoke with Josh Snow, Director of Business Development and Marketing Strategy at Mirus Bio, about the past, present, and future of gene therapy, with a focus on how researchers can transition their successful therapies to clinical trials and the market, and the costs involved.

This episode is brought to you by Mirus Bio. Mirus Bio pioneered scientific breakthroughs in non-viral gene delivery and continues to produce world-class transfection reagents. Now as a global leader in transfection technology, Mirus Bio provides life scientists with the most advanced tools for gene expression, biotherapeutic protein production, virus manufacturing and genome editing.